LivaNova PLC is 1.7x more valuable than TransMedics Group, Inc. by market capitalization ($4.31 B vs $2.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIVN | TMDX |
|---|---|---|
| Market cap | $4.31 B | $2.58 B |
| US-listed rank | #1512 | #1917 |
| Revenue (latest FY) | $1.39B | $605.49M |
| Net income (latest FY) | -$242.50M | $190.30M |
| Net margin | -17.5% | 31.4% |
| P/E (trailing FY) | - | 13.6 |
| SEC filings | 917 | 615 |
LivaNova PLC is 1.7x more valuable than TransMedics Group, Inc. by market capitalization ($4.31 B vs $2.58 B).
In their latest fiscal years, LivaNova PLC reported $1.39B in revenue while TransMedics Group, Inc. reported $605.49M.
Full pages: LivaNova PLC and TransMedics Group, Inc., or browse the full rankings.